Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Autor: Body, J.-J. *, Diel, I.J., Lichinitser, M.R., Kreuser, E.D., Dornoff, W., Gorbunova, V.A., Budde, M., Bergström, B.
Zdroj: In Annals of Oncology September 2003 14(9):1399-1405
Databáze: ScienceDirect